SNW(600628)2024-10-30 09:41Financial Performance - The company's operating revenue for Q3 2024 was ¥266,412,281.79, a decrease of 2.83% compared to the same period last year[2]. - Net profit attributable to shareholders for the same period was ¥18,896,557.31, an increase of 39.21% year-on-year[2]. - The basic earnings per share for Q3 2024 was ¥0.03, reflecting a 50.00% increase compared to the previous year[5]. - Total operating revenue for the first three quarters of 2024 reached ¥806,810,686.48, a slight increase from ¥806,498,128.72 in the same period of 2023[11]. - Net profit for the first three quarters of 2024 was ¥64,790,469.22, up from ¥51,664,479.43 in the previous year, indicating a growth of approximately 25.3%[11]. - Earnings per share increased to ¥0.10 from ¥0.08, showing improved profitability on a per-share basis[11]. - The company achieved an operating profit of ¥78,895,531.88, compared to ¥67,322,918.48 in the same period last year, marking a year-over-year increase of approximately 17.5%[11]. - Other comprehensive income after tax amounted to ¥1,144,046.00, compared to a loss of ¥318,564.63 in the previous year, indicating a positive shift in comprehensive income[11]. Assets and Liabilities - The total assets at the end of the reporting period were ¥5,593,455,838.02, a decrease of 1.63% from the end of the previous year[2]. - Total current assets as of September 30, 2024, amounted to CNY 2,290,596,229.26, a decrease from CNY 2,323,791,731.75 at the end of 2023, reflecting a decline of approximately 1.4%[8]. - The company's inventory decreased to CNY 175,101,967.32 from CNY 188,709,690.90, indicating a reduction of approximately 7.2%[8]. - Long-term equity investments stood at CNY 21,066,880.51, down from CNY 23,066,880.51, showing a decline of about 8.7%[8]. - The company reported a total liability of ¥1,365,866,118.29, down from ¥1,504,697,345.77, indicating a reduction in financial obligations[10]. - Total equity remained stable at ¥646,875,384.00, unchanged from the previous year, reflecting consistent shareholder value[10]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥115,913,453.14, showing a decrease of 14.43% compared to the previous year[2]. - In the first three quarters of 2024, the cash inflow from operating activities reached CNY 1,085,072,874.60, an increase from CNY 980,522,004.23 in the same period of 2023, representing a growth of approximately 10.7%[12]. - The net cash flow from operating activities for the first three quarters of 2024 was CNY 115,913,453.14, down from CNY 135,466,466.45 in 2023, indicating a decrease of about 14.5%[12]. - The cash inflow from investment activities totaled CNY 2,908,079,968.64, slightly up from CNY 2,899,387,330.44 in the previous year, showing a marginal increase of 0.6%[12]. - The net cash flow from investment activities improved to CNY 242,593,506.69 in 2024, compared to a negative cash flow of CNY -208,766,600.78 in 2023[12]. - The cash inflow from financing activities was CNY 656,250,000.00, compared to CNY 593,003,200.48 in the same period last year, reflecting an increase of approximately 10.7%[12]. - The net cash flow from financing activities showed a deficit of CNY -38,286,703.33, an improvement from the deficit of CNY -52,775,267.35 in 2023[12]. - The total cash and cash equivalents at the end of the third quarter of 2024 amounted to CNY 1,449,257,035.37, up from CNY 1,150,647,351.99 at the end of the same period in 2023, marking an increase of about 25.9%[12]. Shareholder Information - The top shareholder, Shanghai Huangpu District State-owned Assets Supervision and Administration Commission, holds 20.73% of shares, totaling 134,074,446 shares[6]. - The second-largest shareholder, Shanghai Zongyi Holdings Co., Ltd., owns 13.07% of shares, amounting to 84,524,934 shares[6]. - The company reported a total of 33,339 common shareholders at the end of the reporting period[6]. - The company has no significant changes in the participation of major shareholders in margin financing and securities lending activities[7]. - There are no other significant reminders regarding the company's operational situation during the reporting period[7]. Cost Management - Total operating costs decreased to ¥741,545,621.17 from ¥752,659,408.68 year-over-year, reflecting a cost reduction strategy[11]. - The financial expenses decreased to ¥9,133,888.43 from ¥9,747,261.91, indicating effective cost management in financing[11]. - The company's deferred income tax liabilities were reported at ¥1,013,454.92, a slight decrease from ¥1,339,539.52, suggesting improved tax management[10]. Prepayments and Investments - The company reported a significant increase of 249.66% in prepaid accounts due to increased project prepayments for the Shanghai Xu Zhong Dao Chinese Medicine Production Base[4]. - The company experienced a 36.90% decrease in trading financial assets primarily due to the redemption of structured deposits[4]. - The company recorded a total of ¥2,797,051.00 in non-recurring gains and losses for the year-to-date[3].